Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1Classical hematology 1

Conditions

Venous Thromboembolism 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Thrombosis 1Ovarian Neoplasms 1Neoplasms 1Endometrial Neoplasms 1

Interventions

Epoetin Alfa 25Darbepoetin alfa 17apixaban 9Rivaroxaban 9Dalteparin 7Heparin, Low-Molecular-Weight 6Surveys and Questionnaires 5Meropenem 5fludarabine phosphate 4Vancomycin 4Tinzaparin 4Enoxaparin 4Cyclosporine 4Cefepime 4ferric carboxymaltose 3edoxaban 3Whole-Body Irradiation 3Peripheral Blood Stem Cell Transplantation 3Mycophenolic Acid 3Ceftazidime 3Carboplatin 3Busulfan 3Antilymphocyte Serum 3Amikacin 3romiplostim 2peginesatide 2hematide 2fludarabine 2epoetin beta 2bemiparin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Anticoagulants × Classical hematology × Clear all
NCT06284343 2024-09-19

GynCAT

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
1,800 enrolled
Classical hematologyGynecologic

Uterine Cervical Neoplasms, Neoplasms, Ovarian Neoplasms, Thrombosis, Vaginal Neoplasms, Endometrial Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡